Delivery Order SPE2DB20D3103-SPE2DB25FP7V0
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,479.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Methylphenidate ER 36 mg tablets in a quantity of 100 units, with a ceiling value of $1,190.40. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. The contract was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,150.33. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the federal pharmaceutical procurement process. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.08 for methylphenidate ER 36 mg tablets (100-count supply) on July 22, 2025, with ultimate completion by July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a firm fixed price of $1,260.63. This non-set-aside, competitively awarded contract is classified as a delivery order under a larger indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement and is a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,017.91 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units. This is a firm fixed price, non-set-aside competitive award with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The delivery order was issued on July 29, 2025, under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a ceiling value of $2,358.46. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 MG tablets (100-count) with a ceiling value of $2,512.53. This is a firm fixed price delivery order with no set-aside designation, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count packages) with a contract value of $2,196.52. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively determined. The order is scheduled for completion by July 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100 count) with a ceiling value of $2,544.82. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The product will be delivered to the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP7V0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 36 mg, with a ceiling value of $1,366.06. This competitively awarded, firm fixed-price contract was executed on August 7, 2025, with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a relatively small-value transaction typical of routine pharmaceutical procurement within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support globally, enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal health systems. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen leverages this framework to fulfill routine and specialized medical procurement requirements for the Department of Defense and its beneficiary populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/7/25 |